EMEA (Europe, Middle East and Africa) RNA Drugs Market Report 2018

EMEA (Europe, Middle East and Africa) RNA Drugs Market Report 2018

1 RNA Drugs Overview

1.1 Product Overview and Scope of RNA Drugs

1.2 Classification of RNA Drugs

1.2.1 EMEA RNA Drugs Market Size (Sales) Comparison by Type (2013-2025)

1.2.2 EMEA RNA Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017

1.2.3 siRNA

1.2.4 ASO

1.2.5 miRNA

1.2.6 Nucleic Acid Aptamers

1.3 EMEA RNA Drugs Market by Application/End Users

1.3.1 EMEA RNA Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)

1.3.2 Cancer

1.3.3 Diabetes

1.3.4 Tuberculosis

1.3.5 Cardiovascular Diseases

1.3.6 Others

1.4 EMEA RNA Drugs Market by Region

1.4.1 EMEA RNA Drugs Market Size (Value) Comparison by Region (2013-2025)

1.4.2 Europe Status and Prospect (2013-2025)

1.4.3 Middle East Status and Prospect (2013-2025)

1.4.4 Africa Status and Prospect (2013-2025)

1.5 EMEA Market Size (Value and Volume) of RNA Drugs (2013-2025)

1.5.1 EMEA RNA Drugs Sales and Growth Rate (2013-2025)

1.5.2 EMEA RNA Drugs Revenue and Growth Rate (2013-2025)

2 EMEA RNA Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA RNA Drugs Market Competition by Players/Manufacturers

2.1.1 EMEA RNA Drugs Sales Volume and Market Share of Major Players (2013-2018)

2.1.2 EMEA RNA Drugs Revenue and Share by Players (2013-2018)

2.1.3 EMEA RNA Drugs Sale Price by Players (2013-2018)

2.2 EMEA RNA Drugs (Volume and Value) by Type/Product Category

2.2.1 EMEA RNA Drugs Sales and Market Share by Type (2013-2018)

2.2.2 EMEA RNA Drugs Revenue and Market Share by Type (2013-2018)

2.2.3 EMEA RNA Drugs Sale Price by Type (2013-2018)

2.3 EMEA RNA Drugs (Volume) by Application

2.4 EMEA RNA Drugs (Volume and Value) by Region

2.4.1 EMEA RNA Drugs Sales and Market Share by Region (2013-2018)

2.4.2 EMEA RNA Drugs Revenue and Market Share by Region (2013-2018)

2.4.3 EMEA RNA Drugs Sales Price by Region (2013-2018)

3 Europe RNA Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe RNA Drugs Sales and Value (2013-2018)

3.1.1 Europe RNA Drugs Sales Volume and Growth Rate (2013-2018)

3.1.2 Europe RNA Drugs Revenue and Growth Rate (2013-2018)

3.2 Europe RNA Drugs Sales and Market Share by Type

3.3 Europe RNA Drugs Sales and Market Share by Application

3.4 Europe RNA Drugs Sales Volume and Value (Revenue) by Countries

3.4.1 Europe RNA Drugs Sales Volume by Countries (2013-2018)

3.4.2 Europe RNA Drugs Revenue by Countries (2013-2018)

3.4.3 Germany RNA Drugs Sales and Growth Rate (2013-2018)

3.4.4 France RNA Drugs Sales and Growth Rate (2013-2018)

3.4.5 UK RNA Drugs Sales and Growth Rate (2013-2018)

3.4.6 Russia RNA Drugs Sales and Growth Rate (2013-2018)

3.4.7 Italy RNA Drugs Sales and Growth Rate (2013-2018)

3.4.8 Benelux RNA Drugs Sales and Growth Rate (2013-2018)

4 Middle East RNA Drugs (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East RNA Drugs Sales and Value (2013-2018)

4.1.1 Middle East RNA Drugs Sales Volume and Growth Rate (2013-2018)

4.1.2 Middle East RNA Drugs Revenue and Growth Rate (2013-2018)

4.2 Middle East RNA Drugs Sales and Market Share by Type

4.3 Middle East RNA Drugs Sales and Market Share by Application

4.4 Middle East RNA Drugs Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East RNA Drugs Sales Volume by Countries (2013-2018)

4.4.2 Middle East RNA Drugs Revenue by Countries (2013-2018)

4.4.3 Saudi Arabia RNA Drugs Sales and Growth Rate (2013-2018)

4.4.4 Israel RNA Drugs Sales and Growth Rate (2013-2018)

4.4.5 UAE RNA Drugs Sales and Growth Rate (2013-2018)

4.4.6 Iran RNA Drugs Sales and Growth Rate (2013-2018)

5 Africa RNA Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa RNA Drugs Sales and Value (2013-2018)

5.1.1 Africa RNA Drugs Sales Volume and Growth Rate (2013-2018)

5.1.2 Africa RNA Drugs Revenue and Growth Rate (2013-2018)

5.2 Africa RNA Drugs Sales and Market Share by Type

5.3 Africa RNA Drugs Sales and Market Share by Application

5.4 Africa RNA Drugs Sales Volume and Value (Revenue) by Countries

5.4.1 Africa RNA Drugs Sales Volume by Countries (2013-2018)

5.4.2 Africa RNA Drugs Revenue by Countries (2013-2018)

5.4.3 South Africa RNA Drugs Sales and Growth Rate (2013-2018)

5.4.4 Nigeria RNA Drugs Sales and Growth Rate (2013-2018)

5.4.5 Egypt RNA Drugs Sales and Growth Rate (2013-2018)

5.4.6 Algeria RNA Drugs Sales and Growth Rate (2013-2018)

6 EMEA RNA Drugs Manufacturers/Players Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 RNA Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Roche

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 RNA Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Sanofi-Aventis

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 RNA Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Abbott Laboratories

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 RNA Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Arrowhead Pharmaceuticals

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 RNA Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Benitec Biopharma

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 RNA Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Calimmune Inc

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 RNA Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Dicerna

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 RNA Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Gradalis

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 RNA Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Quark

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 RNA Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 RXi

6.12 Senesco

6.13 Silence Therapeutics

6.14 Silenseed

6.15 Tekmira

6.16 Alnylam Pharmaceuticals

7 RNA Drugs Manufacturing Cost Analysis

7.1 RNA Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of RNA Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 RNA Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of RNA Drugs Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA RNA Drugs Market Forecast (2018-2025)

11.1 EMEA RNA Drugs Sales, Revenue and Price Forecast (2018-2025)

11.1.1 EMEA RNA Drugs Sales and Growth Rate Forecast (2018-2025)

11.1.2 EMEA RNA Drugs Revenue and Growth Rate Forecast (2018-2025)

11.1.3 EMEA RNA Drugs Price and Trend Forecast (2018-2025)

11.2 EMEA RNA Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.3 Europe RNA Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.4 Middle Eastt RNA Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.5 Africa RNA Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)

11.6 EMEA RNA Drugs Sales Forecast by Type (2018-2025)

11.7 EMEA RNA Drugs Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of RNA Drugs

Figure EMEA RNA Drugs Sales Volume (K Units) by Type (2013-2025)

Figure EMEA RNA Drugs Sales Volume Market Share by Type (Product Category) in 2017

Figure siRNA Product Picture

Figure ASO Product Picture

Figure miRNA Product Picture

Figure Nucleic Acid Aptamers Product Picture

Figure EMEA RNA Drugs Sales Volume (K Units) by Application (2013-2025)

Figure EMEA Sales Market Share of RNA Drugs by Application in 2017

Figure Cancer Examples

Table Key Downstream Customer in Cancer

Figure Diabetes Examples

Table Key Downstream Customer in Diabetes

Figure Tuberculosis Examples

Table Key Downstream Customer in Tuberculosis

Figure Cardiovascular Diseases Examples

Table Key Downstream Customer in Cardiovascular Diseases

Figure Others Examples

Table Key Downstream Customer in Others

Figure EMEA RNA Drugs Market Size (Million USD) by Region (2013-2025)

Figure Europe RNA Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe RNA Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Middle East RNA Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Middle East RNA Drugs Revenue (Million USD) Status and Forecast by Countries

Figure Africa RNA Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Africa RNA Drugs Revenue (Million USD) Status and Forecast by Countries

Figure EMEA RNA Drugs Sales Volume and Growth Rate (2013-2025)

Figure EMEA RNA Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure EMEA RNA Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)

Table EMEA RNA Drugs Sales Volume (K Units) of Major Players (2013-2018)

Table EMEA RNA Drugs Sales Share by Players (2013-2018)

Figure 2017 RNA Drugs Sales Share by Players

Figure 2017 RNA Drugs Sales Share by Players

Figure EMEA RNA Drugs Market Major Players Product Revenue (Million USD) (2013-2018)

Table EMEA RNA Drugs Revenue (Million USD) by Players (2013-2018)

Table EMEA RNA Drugs Revenue Share by Players (2013-2018)

Table 2017 EMEA RNA Drugs Revenue Share by Players

Table 2017 EMEA RNA Drugs Revenue Share by Players

Table EMEA RNA Drugs Sale Price (USD/Unit) by Players (2013-2018)

Table EMEA RNA Drugs Sales (K Units) and Market Share by Type (2013-2018)

Table EMEA RNA Drugs Sales Share by Type (2013-2018)

Figure Sales Market Share of RNA Drugs by Type (2013-2018)

Figure EMEA RNA Drugs Sales Market Share by Type (2013-2018)

Table EMEA RNA Drugs Revenue (Million USD) and Market Share by Type (2013-2018)

Table EMEA RNA Drugs Revenue Share by Type (2013-2018)

Figure Revenue Market Share of RNA Drugs by Type in 2017

Table EMEA RNA Drugs Sale Price (USD/Unit) by Type (2013-2018)

Table EMEA RNA Drugs Sales (K Units) and Market Share by Application (2013-2018)

Table EMEA RNA Drugs Sales Share by Application (2013-2018)

Figure Sales Market Share of RNA Drugs by Application (2013-2018)

Figure EMEA RNA Drugs Sales Market Share by Application in 2017

Table EMEA RNA Drugs Sales (K Units) and Market Share by Region (2013-2018)

Table EMEA RNA Drugs Sales Share by Region (2013-2018)

Figure Sales Market Share of RNA Drugs by Region (2013-2018)

Figure EMEA RNA Drugs Sales Market Share in 2017

Table EMEA RNA Drugs Revenue (Million USD) and Market Share by Region (2013-2018)

Table EMEA RNA Drugs Revenue Share by Region (2013-2018)

Figure Revenue Market Share of RNA Drugs by Region (2013-2018)

Figure EMEA RNA Drugs Revenue Market Share Regions in 2017

Table EMEA RNA Drugs Sales Price (USD/Unit) by Region (2013-2018)

Figure Europe RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Europe RNA Drugs Revenue and Growth Rate (2013-2018)

Table Europe RNA Drugs Sales (K Units) by Type (2013-2018)

Table Europe RNA Drugs Market Share by Type (2013-2018)

Figure Europe RNA Drugs Market Share by Type in 2017

Table Europe RNA Drugs Sales (K Units) by Application (2013-2018)

Table Europe RNA Drugs Market Share by Application (2013-2018)

Figure Europe RNA Drugs Market Share by Application in 2017

Table Europe RNA Drugs Sales (K Units) by Countries (2013-2018)

Table Europe RNA Drugs Sales Market Share by Countries (2013-2018)

Figure Europe RNA Drugs Sales Market Share by Countries (2013-2018)

Figure Europe RNA Drugs Sales Market Share by Countries in 2017

Table Europe RNA Drugs Revenue (Million USD) by Countries (2013-2018)

Table Europe RNA Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe RNA Drugs Revenue Market Share by Countries (2013-2018)

Figure Europe RNA Drugs Revenue Market Share by Countries in 2017

Figure Germany RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure France RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure UK RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Russia RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Italy RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Benelux RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Middle East RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Middle East RNA Drugs Revenue (Million USD) and Growth Rate (2013-2018)

Table Middle East RNA Drugs Sales (K Units) by Type (2013-2018)

Table Middle East RNA Drugs Market Share by Type (2013-2018)

Figure Middle East RNA Drugs Market Share by Type (2013-2018)

Table Middle East RNA Drugs Sales (K Units) by Applications (2013-2018)

Table Middle East RNA Drugs Market Share by Applications (2013-2018)

Figure Middle East RNA Drugs Sales Market Share by Application in 2017

Table Middle East RNA Drugs Sales Volume (K Units) by Countries (2013-2018)

Table Middle East RNA Drugs Sales Volume Market Share by Countries (2013-2018)

Figure Middle East RNA Drugs Sales Volume Market Share by Countries in 2017

Table Middle East RNA Drugs Revenue (Million USD) by Countries (2013-2018)

Table Middle East RNA Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East RNA Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East RNA Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Israel RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure UAE RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Iran RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Africa RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Africa RNA Drugs Revenue (Million USD) and Growth Rate (2013-2018)

Table Africa RNA Drugs Sales (K Units) by Type (2013-2018)

Table Africa RNA Drugs Sales Market Share by Type (2013-2018)

Figure Africa RNA Drugs Sales Market Share by Type (2013-2018)

Figure Africa RNA Drugs Sales Market Share by Type in 2017

Table Africa RNA Drugs Sales (K Units) by Application (2013-2018)

Table Africa RNA Drugs Sales Market Share by Application (2013-2018)

Figure Africa RNA Drugs Sales Market Share by Application (2013-2018)

Table Africa RNA Drugs Sales Volume (K Units) by Countries (2013-2018)

Table Africa RNA Drugs Sales Market Share by Countries (2013-2018)

Figure Africa RNA Drugs Sales Market Share by Countries (2013-2018)

Figure Africa RNA Drugs Sales Market Share by Countries in 2017

Table Africa RNA Drugs Revenue (Million USD) by Countries (2013-2018)

Table Africa RNA Drugs Revenue Market Share by Countries (2013-2018)

Figure Africa RNA Drugs Revenue Market Share by Countries (2013-2018)

Figure Africa RNA Drugs Revenue Market Share by Countries in 2017

Figure South Africa RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Nigeria RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Egypt RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Algeria RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Table Pfizer RNA Drugs Basic Information List

Table Pfizer RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Pfizer RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Pfizer RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Roche RNA Drugs Basic Information List

Table Roche RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Roche RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Roche RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Roche RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Sanofi-Aventis RNA Drugs Basic Information List

Table Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sanofi-Aventis RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Sanofi-Aventis RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Sanofi-Aventis RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Abbott Laboratories RNA Drugs Basic Information List

Table Abbott Laboratories RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Abbott Laboratories RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Abbott Laboratories RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Abbott Laboratories RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Arrowhead Pharmaceuticals RNA Drugs Basic Information List

Table Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Arrowhead Pharmaceuticals RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Arrowhead Pharmaceuticals RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Arrowhead Pharmaceuticals RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Benitec Biopharma RNA Drugs Basic Information List

Table Benitec Biopharma RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Benitec Biopharma RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Benitec Biopharma RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Benitec Biopharma RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Calimmune Inc RNA Drugs Basic Information List

Table Calimmune Inc RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Calimmune Inc RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Calimmune Inc RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Calimmune Inc RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Dicerna RNA Drugs Basic Information List

Table Dicerna RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Dicerna RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Dicerna RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Dicerna RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Gradalis RNA Drugs Basic Information List

Table Gradalis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Gradalis RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Gradalis RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Gradalis RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table Quark RNA Drugs Basic Information List

Table Quark RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Quark RNA Drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Quark RNA Drugs Sales Market Share in EMEA (2013-2018)

Figure Quark RNA Drugs Revenue Market Share in EMEA (2013-2018)

Table RXi RNA Drugs Basic Information List

Table Senesco RNA Drugs Basic Information List

Table Silence Therapeutics RNA Drugs Basic Information List

Table Silenseed RNA Drugs Basic Information List

Table Tekmira RNA Drugs Basic Information List

Table Alnylam Pharmaceuticals RNA Drugs Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of RNA Drugs

Figure Manufacturing Process Analysis of RNA Drugs

Figure RNA Drugs Industrial Chain Analysis

Table Raw Materials Sources of RNA Drugs Major Manufacturers in 2017

Table Major Buyers of RNA Drugs

Table Distributors/Traders List

Figure EMEA RNA Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure EMEA RNA Drugs Revenue and Growth Rate Forecast (2018-2025)

Figure EMEA RNA Drugs Price (USD/Unit) and Trend Forecast (2018-2025)

Table EMEA RNA Drugs Sales (K Units) Forecast by Region (2018-2025)

Figure EMEA RNA Drugs Sales Market Share Forecast by Region (2018-2025)

Table EMEA RNA Drugs Revenue (Million USD) Forecast by Region (2018-2025)

Figure EMEA RNA Drugs Revenue Market Share Forecast by Region (2018-2025)

Table Europe RNA Drugs Sales (K Units) Forecast by Countries (2018-2025)

Figure Europe RNA Drugs Sales Market Share Forecast by Countries (2018-2025)

Table Europe RNA Drugs Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Europe RNA Drugs Revenue Market Share Forecast by Countries (2018-2025)

Table Middle East RNA Drugs Sales (K Units) Forecast by Countries (2018-2025)

Figure Middle East RNA Drugs Sales Market Share Forecast by Countries (2018-2025)

Table Middle East RNA Drugs Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Middle East RNA Drugs Revenue Market Share Forecast by Countries (2018-2025)

Table Africa RNA Drugs Sales (K Units) Forecast by Countries (2018-2025)

Figure Africa RNA Drugs Sales Market Share Forecast by Countries (2018-2025)

Table Africa RNA Drugs Revenue (Million USD) Forecast by Countries (2018-2025)

Figure Africa RNA Drugs Revenue Market Share Forecast by Countries (2018-2025)

Table EMEA RNA Drugs Sales (K Units) Forecast by Type (2018-2025)

Figure EMEA RNA Drugs Sales Market Share Forecast by Type (2018-2025)

Table EMEA RNA Drugs Sales (K Units) Forecast by Application (2018-2025)

Figure EMEA RNA Drugs Sales Market Share Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources